1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34890965 | Nafamostat mesylate overcomes endocrine resistance of breast cancer through epigenetic regulation of CDK4 and CDK6 expression. | 2022 Jan | 3 |